HUMANISTIC BURDEN OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA FROM THE PATIENT PERSPECTIVE: RESULTS FROM A CROSS-SECTIONAL STUDY

被引：0
|
作者：
Panse, J. [1 ]
O'Neill, C. B. [2 ]
Wiyani, A. [3 ]
Snellman, J. [4 ]
Mellor, J. [5 ]
Earl, L. [5 ]
Taylor, Y. [5 ]
Simons, A. [5 ]
Balp, M. M. [4 ]
机构：
[1] Univ Hosp RWTH Aachen, Aachen, Germany
[2] Novartis Business Serv, Dublin, Dublin, Ireland
[3] Novartis Corp Malaysia, Petaling Jaya, Selangor, Malaysia
[4] Novartis Pharma AG, Basel, Switzerland
[5] Adelphi Real World, Bollington, Cheshire, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR42
引用
收藏
页码：S456 / S456
页数：1
相关论文
共 50 条
  • [21] A Case of Paroxysmal Nocturnal Hemoglobinuria (PNH) in an Obstetric Patient: A South African Perspective
    Laudin, Garrick
    Wium, Lizemarie
    CLINICAL MANAGEMENT ISSUES, 2019, 13 (01) : 1 - 5
  • [22] Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective
    Fattizzo, Bruno
    Cavallaro, Francesca
    Oliva, Esther Natalie
    Barcellini, Wilma
    JOURNAL OF BLOOD MEDICINE, 2022, 13 : 327 - 335
  • [23] Hospital choice in Germany from the patient’s perspective: a cross-sectional study
    Werner de Cruppé
    Max Geraedts
    BMC Health Services Research, 17
  • [24] Hospital choice in Germany from the patient's perspective: a cross-sectional study
    de Cruppe, Werner
    Geraedts, Max
    BMC HEALTH SERVICES RESEARCH, 2017, 17
  • [25] The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey
    David Dingli
    Joana E. Matos
    Kerri Lehrhaupt
    Sangeeta Krishnan
    Michael Yeh
    Jesse Fishman
    Sujata P. Sarda
    Scott B. Baver
    Annals of Hematology, 2022, 101 : 251 - 263
  • [26] Pregnancy in paroxysmal nocturnal hemoglobinuria: from survival to life
    Vinogradova, Maria A.
    Kulagin, Alexander D.
    Shmakov, Roman G.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (07) : 859 - 864
  • [27] The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey
    Dingli, David
    Matos, Joana E.
    Lehrhaupt, Kerri
    Krishnan, Sangeeta
    Yeh, Michael
    Fishman, Jesse
    Sarda, Sujata P.
    Baver, Scott B.
    ANNALS OF HEMATOLOGY, 2022, 101 (02) : 251 - 263
  • [28] Paroxysmal nocturnal hemoglobinuria arising from Fanconi anemia
    Wainwright, L
    Brodsky, RA
    Erasmus, LK
    Poyiadjis, S
    Naidu, G
    MacKinnon, D
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (02) : 167 - 168
  • [29] RESULTS FROM A NATIONAL CROSS-SECTIONAL STUDY OF DISEASE BURDEN IN CROHN'S DISEASE
    Seabury, Jamison
    Zizzi, Christine
    Weinstein, Jennifer
    Wagner, Ellen
    Rosero, Spencer
    Dilek, Nuran
    Kaat, Aaron
    McDermott, Michael
    Saubermann, Lawrence
    Temple, Larissa
    Rogoff, Scott
    Heatwole, Chad
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S13 - S13
  • [30] RESULTS FROM A NATIONAL CROSS-SECTIONAL STUDY OF DISEASE BURDEN IN CROHN'S DISEASE
    Seabury, Jamison
    Zizzi, Christine
    Weinstein, Jennifer
    Wagner, Ellen
    Rosero, Spencer
    Dilek, Nuran
    Kaat, Aaron
    McDermott, Michael
    Saubermann, Lawrence
    Temple, Larissa
    Rogoff, Scott
    Heatwole, Chad
    GASTROENTEROLOGY, 2021, 160 (03) : S18 - S18
12345